Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Blood Brain Barrier Penetration and Pharmacokinetics of the Elemene in Malignant Patients.

NCT01679847 is registered in ClinicalTrials.gov with Dalian Holley Kingkong Pharmaceutical Co., Ltd as lead sponsor.

NCT NCT01679847
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01679847 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Blood Brain Barrier Penetration and Pharmacokinetics of the Elemene in Malignant Patients.
Lead sponsor
Dalian Holley Kingkong Pharmaceutical Co., Ltd
Phase
Observational
Overall status
Unknown status
Start date
September 30, 2012
Completion date
June 30, 2013
Enrollment
8 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer